Cuu Long Pharmaceutical Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Cuu Long Pharmaceutical has a total shareholder equity of ₫1,483.9B and total debt of ₫750.6B, which brings its debt-to-equity ratio to 50.6%. Its total assets and total liabilities are ₫2,396.5B and ₫912.7B respectively. Cuu Long Pharmaceutical's EBIT is ₫72.2B making its interest coverage ratio 3.9. It has cash and short-term investments of ₫226.9B.
Belangrijke informatie
50.6%
Verhouding schuld/eigen vermogen
₫750.60b
Schuld
| Rente dekkingsratio | 3.9x |
| Contant | ₫226.89b |
| Aandelen | ₫1.48t |
| Totaal verplichtingen | ₫912.68b |
| Totaal activa | ₫2.40t |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: DCL's short term assets (₫1,428.6B) exceed its short term liabilities (₫630.4B).
Langlopende schulden: DCL's short term assets (₫1,428.6B) exceed its long term liabilities (₫282.3B).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: DCL's net debt to equity ratio (35.3%) is considered satisfactory.
Schuld verminderen: DCL's debt to equity ratio has reduced from 95.2% to 50.6% over the past 5 years.
Schuldendekking: DCL's operating cash flow is negative, therefore debt is not well covered.
Rentedekking: DCL's interest payments on its debt are well covered by EBIT (3.9x coverage).